Russell Investments Group’s Royalty Pharma RPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $47.1M | Sell |
1,307,264
-286,493
| -18% | -$10.3M | 0.06% | 327 |
|
|
2025
Q1 | $49.6M | Sell |
1,593,757
-262,034
| -14% | -$8.16M | 0.07% | 296 |
|
|
2024
Q4 | $47.3M | Buy |
1,855,791
+449,551
| +32% | +$11.5M | 0.07% | 310 |
|
|
2024
Q3 | $39.8M | Buy |
1,406,240
+587,281
| +72% | +$16.6M | 0.06% | 344 |
|
|
2024
Q2 | $21.6M | Buy |
818,959
+416,816
| +104% | +$11M | 0.03% | 504 |
|
|
2024
Q1 | $12.2M | Buy |
402,143
+79,176
| +25% | +$2.41M | 0.02% | 740 |
|
|
2023
Q4 | $9.05M | Buy |
322,967
+54,907
| +20% | +$1.54M | 0.02% | 835 |
|
|
2023
Q3 | $7.23M | Sell |
268,060
-38,140
| -12% | -$1.03M | 0.01% | 905 |
|
|
2023
Q2 | $9.39M | Sell |
306,200
-120,408
| -28% | -$3.69M | 0.02% | 806 |
|
|
2023
Q1 | $15.4M | Buy |
426,608
+45,157
| +12% | +$1.63M | 0.03% | 605 |
|
|
2022
Q4 | $15.1M | Sell |
381,451
-2,286
| -0.6% | -$90.4K | 0.03% | 617 |
|
|
2022
Q3 | $15.4M | Buy |
383,737
+47,070
| +14% | +$1.89M | 0.03% | 582 |
|
|
2022
Q2 | $14.2M | Buy |
336,667
+317,107
| +1,621% | +$13.3M | 0.03% | 634 |
|
|
2022
Q1 | $761K | Buy |
19,560
+11,980
| +158% | +$466K | ﹤0.01% | 2086 |
|
|
2021
Q4 | $301K | Sell |
7,580
-439
| -5% | -$17.4K | ﹤0.01% | 2606 |
|
|
2021
Q3 | $289K | Buy |
8,019
+6,924
| +632% | +$250K | ﹤0.01% | 2660 |
|
|
2021
Q2 | $44K | Sell |
1,095
-255
| -19% | -$10.2K | ﹤0.01% | 3140 |
|
|
2021
Q1 | $58K | Sell |
1,350
-134,555
| -99% | -$5.78M | ﹤0.01% | 3024 |
|
|
2020
Q4 | $6.8M | Buy |
135,905
+132,444
| +3,827% | +$6.63M | 0.01% | 1073 |
|
|
2020
Q3 | $145K | Buy |
+3,461
| New | +$145K | ﹤0.01% | 2896 |
|